Valisure is an American independent laboratory focused on the testing the purity and safety of pharmaceutical drugs and consumer products.
[2] After taking an anticonvulsant medication and experiencing negative side effects due to the poor quality of the drug, Clark-Joseph contacted Light about establishing a business testing pharmaceutical products.
[1] In 2019, Valisure reported that it had tested Zantac and generic equivalents and discovered that they contained N-Nitrosodimethylamine, which is thought to be a carcinogen.
[3][4][5] In February 2024, Valisure announced Chip Phillips as their new CEO, succeeding David Light.
[6] Clients of Valisure include Kaiser Permanente and the United States Armed Forces.